You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again

    SBC: Countervail Corporation            Topic: NINDS

    DESCRIPTION provided by applicant Fast Track SBIR Phase I and Phase II Exposure to centrally acting military nerve agents and organophosphorus OP pesticides are known to cause death and neurological damage Coupland Karalliedee Buckley Improved countermeasures to intoxication from these compounds are needed In numerous studies Albuquerque conducted at the University of Maryland School of Medicine U ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Drug and Alcohol Prevention for College Athletes

    SBC: Prevention Strategies, LLC            Topic: NIDA

    DESCRIPTION provided by applicant College student athletes are at increased risk of heavy alcohol use smokeless tobacco use and the use of performance enhancing substances as compared to non athlete college students Despite recent research underscoring the need for athlete tailored interventions there are no evidence based options for the prevention of substance use among college student at ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Development of an extremely efficient nebulizer for intranasal vaccination

    SBC: CREARE LLC            Topic: N/A

    Extremely Efficient Nebulizer for Intranasal Vaccination. Specifically the nasal delivery device could reduce health care associated infections by providing a needle-free method of delivery of vaccines and therapeutics which are currently delivered by injection with all the attendant risks of transmission of blood borne disease through needle-stick injury and unsafe needle practices. One of the m ...

    SBIR Phase II 2011 Department of Health and Human ServicesCenters for Disease Control and Prevention
  4. Development of a Database Management System to Enable Rapid, Efficient Assay Design for Use in Detection and Diagnosis of Human Exposure to Biological

    SBC: CFD Research Corporation            Topic: CBD07114

    Increases in amount and diversity of high-throughput data presents tremendous organizational and analysis challenges to researchers. Our objective in this effort is to address these challenges by designing and implementing a database management system (cipherDB) for the storage, management, analysis, and visualization of diverse biological data types. The Phase I design and implementation of ciphe ...

    SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense
  5. Lightweight, Efficient Blower for Personal Air Ventilation System

    SBC: CREARE LLC            Topic: CBD07115

    A personal air ventilation system (PAVS) can dramatically improve the environment inside chemical/biological protective clothing, protecting the health and safety of soldiers and enabling peak physical/mental performance for long periods. However, existing air blowers that can produce the flow rate and pressure drop needed for a PAVS are too heavy, inefficient, and noisy for a man-portable system ...

    SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense
  6. Nanoliter Lab-on-a-Chip for Rapid Parallel Immunoassays

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): The great need for more efficient and effective oncologic drug development has driven the discovery and integration of biomarkers into all phases of clinical research. Further still, biomarkers are entering the clinical arena as early means of determining which patients are likely benefiting from a particular drug. One field of targeted therapy that has relied ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Bioactive Peptide Coatings for Synthetic Bone Grafts in Dental Applications

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): According to the National Institute of Dental and Craniofacial Research, 86% of adults over 70 years of age have at least moderate periodontitis with over a quarter having lost their teeth, resulting in serious health a nd quality of life repercussions. Bone grafting is routinely necessary prior to the placement of Dental implants due to bone loss caused by per ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Point of Care Attachment of Antibiotics onto Metal Implants

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infectio ns, which arise from the establishment of biofilms on device surfaces, not only necessitate new surgeries but in themselves present a significa ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Click Chemistry for Immobilized Bone Morphogenetic Protein

    SBC: AFFINERGY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Growth factors are potent signaling molecules, initiating essential cellular programs for differentiation, proliferation and survival. Only recently have large molecules like growth factors, been employed to enhance the efficacy and specificity of medical implant therapies. In particular, procedures that require native tissues to interact with an implanted mat ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Innovative Tools for the Molecular Diagnosis of Cancer

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The National Cancer Institute has called for new tools for cancer research and diagnosis that are accurate, practical and affordable. Alderon Biosciences, Inc. proposes to fill this need by developing an open biosensor platform technology for quantitative studies of cancer gene expression, with the goal of replacing slower and more costly methods. The working ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government